| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
26,184,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
831,818 |
Avg
Vol: |
829,507 |
| 52
Week Range: |
$0.000001 - $0.0001 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile EPIRUS Biopharmaceuticals is a global biopharmaceutical company focused on building a biosimilar business. Co.'s primary product candidate is BOW015 (infliximab), a monoclonal antibody against tumor necrosis factor alpha, which is used to treat inflammatory diseases. Co.'s other pipeline products, BOW050 (adalimumab), a proposed biosimilar to Humira, BOW070 (tocilizumab), a proposed biosimilar to Actemra, BOW080 (eculizumab), a proposed biosimilar to Soliris, BOW090 (ustekinumab), a proposed biosimilar to STELARA and BOW100 (golimumab), a proposed biosimilar to SIMPONI, are in preclinical development.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wyand Michael |
Chief Technical Officer |
• – – |
2016-02-27 |
4/A |
D |
$2.80 |
$3,858 |
D/D |
(1,378) |
32,662 |
|
- |
|
| Wyand Michael |
Chief Technical Officer |
• – – |
2016-02-27 |
4 |
D |
$2.80 |
$3,861 |
D/D |
(1,379) |
32,661 |
|
- |
|
| Wyand Michael |
Chief Technical Officer |
• – – |
2016-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,652 |
34,040 |
|
- |
|
| Ticktin Robert |
General Counsel |
• – – |
2016-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,083 |
6,083 |
|
- |
|
| Shea Thomas A. |
Chief Financial Officer |
• – – |
2016-02-27 |
4 |
D |
$2.80 |
$4,351 |
D/D |
(1,554) |
31,489 |
|
- |
|
| Shea Thomas A. |
Chief Financial Officer |
• – – |
2016-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,117 |
33,043 |
|
- |
|
| Munshi Amit |
Chief Executive Officer |
• • – |
2016-02-27 |
4 |
D |
$2.80 |
$12,054 |
I/I |
(4,305) |
177,083 |
|
- |
|
| Munshi Amit |
Chief Executive Officer |
• • – |
2016-02-27 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,406 |
181,388 |
|
- |
|
| Ticktin Robert |
General Counsel |
• – – |
2015-12-21 |
4 |
B |
$3.72 |
$11,162 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
| Vincent Aurentz |
Chief Business Officer |
• – – |
2015-12-17 |
4 |
B |
$3.43 |
$7,546 |
D/D |
2,200 |
2,200 |
2.74 |
- |
|
| Munshi Amit |
Chief Executive Officer |
• • – |
2015-12-16 |
4 |
B |
$2.80 |
$23,156 |
I/I |
8,270 |
169,982 |
2.58 |
- |
|
| Munshi Amit |
Chief Executive Officer |
• • – |
2015-12-15 |
4 |
B |
$2.87 |
$23,158 |
I/I |
8,069 |
161,712 |
2.58 |
- |
|
| Vincent Aurentz |
Chief Business Officer |
• – – |
2015-12-09 |
4 |
B |
$3.85 |
$10,780 |
I/I |
2,800 |
2,800 |
1.99 |
- |
|
| Munshi Amit |
Chief Executive Officer |
• • – |
2015-12-09 |
4 |
B |
$4.07 |
$53,683 |
I/I |
13,190 |
153,643 |
2.66 |
- |
|
| Shea Thomas A. |
Chief Financial Officer |
• – – |
2015-11-03 |
4 |
OE |
$1.30 |
$37,604 |
D/D |
28,926 |
28,926 |
|
- |
|
| Munshi Amit |
Chief Executive Officer |
• • – |
2015-09-21 |
4 |
B |
$6.19 |
$61,900 |
I/I |
10,000 |
140,453 |
2.66 |
- |
|
| Munshi Amit |
Chief Executive Officer |
• • – |
2015-09-18 |
4 |
B |
$5.99 |
$59,860 |
I/I |
10,000 |
130,453 |
2.66 |
- |
|
| Wyand Michael |
Chief Technical Officer |
• – – |
2015-09-14 |
4 |
OE |
$1.00 |
$8,747 |
D/D |
8,747 |
30,388 |
|
- |
|
| Munshi Amit |
Chief Executive Officer |
• • – |
2015-07-02 |
4 |
OE |
$1.00 |
$51,200 |
D/D |
51,200 |
120,453 |
|
- |
|
| Montreux Equity Partners V, L.p. |
10% Owner |
– – • |
2015-02-06 |
4 |
S |
$5.01 |
$500,930 |
D/D |
(100,000) |
1,671,400 |
|
- |
|
| Montreux Equity Partners V, L.p. |
10% Owner |
– – • |
2015-02-05 |
4 |
S |
$4.97 |
$334,843 |
D/D |
(67,316) |
1,771,400 |
|
- |
|
| Diekman John D |
10% Owner |
– – • |
2015-02-04 |
4 |
B |
$5.00 |
$2,000,000 |
I/I |
400,000 |
2,549,211 |
1.5 |
- |
|
| Rocklage Scott M |
Director |
– • • |
2015-02-04 |
4 |
B |
$5.00 |
$2,000,000 |
I/I |
400,000 |
2,549,211 |
2.25 |
- |
|
| Montreux Equity Partners V, L.p. |
10% Owner |
– – • |
2015-02-04 |
4 |
S |
$4.95 |
$28,139 |
D/D |
(5,684) |
1,838,716 |
|
- |
|
| Montreux Equity Partners V, L.p. |
10% Owner |
– – • |
2015-02-03 |
4 |
S |
$4.99 |
$234,431 |
D/D |
(47,000) |
1,844,400 |
|
- |
|
36 Records found
|
|
Page 1 of 2 |
|
|
